Загрузка...
Evaluation of Current Cancer Immunotherapy: Haemato-Oncology
Hematological malignancies were the first diseases in clinical oncology for which the potential of harnessing the immune system as targeted therapy was unequivocally demonstrated. Unfortunately the use of this highly efficacious modality has been limited to only a subset of patients and diseases due...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3210818/ https://ncbi.nlm.nih.gov/pubmed/21952281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3182341fde |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|